VIEW OUR POSTERS 
 

Session Category: Tumor Biology

#37   A novel technique to preclinically assess the ability of targeted therapies to inhibit both primary and metastatic non-small cell lung carcinoma 
Erin Trachet
Session Category: Tumor Biology 
Session Title: Novel Models of Human Cancer 
View poster

#41   Growth kinetics and immune cell profiling of BT-474 human breast carcinoma and Raji-Luc human Burkitt lymphoma in triple immunodeficient mice 
Justin Snider 
Session Category: Tumor Biology 
Session Title: Novel Models of Human Cancer 
View poster

#2402   Fractionated dosing: A more clinically relevant approach to radiotherapy in preclinical tumor models 
Kerry Ann Bright 
Session Category: Tumor Biology 
Session Title: Radiation Sciences 
View poster
 

#4654   Differential immunomodulation following checkpoint blockade in the orthotopic ID8-luc ovarian model 
Sheri Barnes 
Session Category: Tumor Biology 
Session Title: Inflammation and Tumor Progression 
View poster

#4561   3D Reconstructed Pancreas: A model capturing the unique tumor microenvironment and stromal architecture of pancreatic cancer 
Dr. Uihlein (Predictive Oncology) 
Session Category: Tumor Biology 
Session Title: 3D and Tissue Recombinant Models 
View poster

#5945   Transcriptional analysis of TME in MC38 colon carcinoma model following checkpoint inhibition 
Priyanka Singh 
Session Category: Tumor Biology 
Session Title: Tumor-Stromal Cell (Including Immune Cell) Interactions and Therapy Responses 
View poster

Session Category: Experimental and Molecular Therapeutics 

#589   Long-term acclimation of target cell lines to tumor microenvironment culture condition provides mechanistic insights into cell therapy effectiveness 
James Lim (Xcell Bio)
Session Category: Experimental and Molecular Therapeutics 
Session Title: Targeting the Tumor Microenvironment 


#2749   Preclinical assessment of chimeric antigen receptor (CAR) T persistence and functionality in the disseminated NALM6-Luc human B cell acute lymphoblastic leukemia (ALL) model 
Dave Draper 
Session Category: Experimental and Molecular Therapeutics 
Session Title: Innovative Assay Technologies 
View poster

#2762    Inhibition of Murine Myeloid Suppressor Cells Increases CD8+ T cell Activation in Vitro 
Anita Zaitouna 
Session Category: Experimental and Molecular Therapeutics 
Session Title: Innovative Assay Technologies 
View poster

Session Category: Immunology

#1782   Functional potency assay predicts CAR-T effectiveness in tumor microenvironment 
Yelena Bronevetsky (Xcell Bio) 
Session Category: Immunology 
Session Title: CAR T-cell Therapy 
 

Session Category: Clinical Research Excluding Trials

#3358   Prognostic value of post surgery liquid biopsy cell free circulating tumor DNA in stage III colon cancer patients PLCRC PROVENC3 study
Carmen Rubio Alarcón
Session Category: Clinical Research Excluding Trials
Session Title: PO.CL01.16 - Liquid Biopsies: Circulating Nucleic Acids and Circulating Tumor Cells 3
View poster

 
#5452   Complimentary use of DNA- and RNA-based NGS assays optimizes detection of clinically relevant translocations for comprehensive genomic profiling
Rongqin Ren
Session Category: Clinical Research Excluding Trials
Session Title: Biomarkers of Therapeutic Benefit 5
View poster

#5587   Ultra-deep targeted sequencing of cell-free DNA and patient-matched white blood cells for treatment response evaluation in patients with metastatic colorectal cancer.
Iris van ‘t Erve
Session Category: Clinical Research Excluding Trials
Session Title: PO.CL01.17 - Liquid Biopsies: Circulating Nucleic Acids and Circulating Tumor Cells 4
View poster


#5597   Enhanced detection and classification of cell-free DNA alterations through matched normal analyses with PGDx elio plasma complete
Tonya N. Watkins
Session Category: Clinical Research Excluding Trials
Session Title: PO.CL01.17 - Liquid Biopsies: Circulating Nucleic Acids and Circulating Tumor Cells 4
View poster

#923   Genomic landscape of patients with non-small cell lung cancer
Neeraj Kumar Singh
Session Category: Clinical Research Excluding Trials    
Session Title: PO.CL11.01 - Analyses Using Clinical and Genomic Databases
View poster

Session Category: Experimental and Molecular Therapeutics  

#6220   Development of a mutation profiling NGS assay to facilitate clinical decisions in hematologic malignancies.
Grant Hogg
Session Category: Experimental and Molecular Therapeutics        
Session Title: DNA Repair / Molecular Classification of Tumors for Diagnostics, Prognostics, and Therapeutic Outcomes / Others
View poster

Session Category: Clinical Trials  

#CT212   A ctDNA-directed, multi-center phase II study of molecular response adaptive immuno-chemotherapy in patients with non-small cell lung cancer: Analysis of Stage 1 of CCTG BR.36
Valsamo Anagnostou
Session Category: Clinical Trials    
Session Title: PO.CT02.02 - Phase II Clinical Trials 2
View poster